About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Washington | 25,884 Studies Near You

Clinical TrialsWashington

Clinical Trials in Washington

Discover 25,884 clinical trials near Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4221-4240 of 25,884 trials

TerminatedA Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)This study is designed to evaluate the safety and efficacy of deflazacort in participants with LGMD2I.NCT03783923·Atlanta, Georgia and 17 others RecruitingBiospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyThis clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer.NCT06651580·Los Angeles, California and 25 others

Find Trials by Condition in Washington

Breast Cancerin Washington Lung Cancerin Washington Prostate Cancerin Washington Colorectal Cancerin Washington Melanomain Washington Leukemiain Washington Lymphomain Washington Pancreatic Cancerin Washington Ovarian Cancerin Washington Brain Cancerin Washington

Data from ClinicalTrials.govTerms

CompletedA Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut SyndromeThe aims of the study are: * to learn if soticlestat, when given as add-on therapy, reduces the number of major motor drop seizures in children, teenagers, and adults with…NCT04938427·Phoenix, Arizona and 97 others

RecruitingDasatinib for HIV-1 Reservoir ReductionThis study will test if the medicine dasatinib can lower the hidden amount of HIV in the body, called the HIV "reservoir." It will also check if dasatinib is safe and easy to take…NCT07342491·Chicago, Illinois and 2 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05736874·Gilbert, Arizona and 86 others

TerminatedTezosentan in Pulmonary Arterial HypertensionMulticenter, Open-label, Non-comparative, Proof-of-concept, Phase 2a Study to Evaluate the Effect of a Single Infusion of Tezosentan on Pulmonary Vascular Resistance in Patients…NCT01077297·St Louis, Missouri and 4 others

CompletedA Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesThis is a 60 week study including a double-blind phase followed by an open-label extension phase.NCT00156910·Seattle, Washington and 1 other

CompletedA Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved DoseThis is a study to test if a new higher dose of Copaxone is more effective in treating relapsing-remitting multiple sclerosis than the currently available 20 mg dose.NCT00202982·La Jolla, California and 19 others

CompletedEffect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 DiabetesThe purpose of this study is to test the hypothesis that in patients with type 2 diabetes, the addition of exenatide will result in lower time-averaged serum glucose during a…NCT00241423·Washington D.C., District of Columbia and 1 other

CompletedTosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeThis study examines a new oral chemotherapy drug called tosedostat, in combination with cytarabine or decitabine.NCT01567059·Seattle, Washington

CompletedThe Acute Burn ResUscitation Multicenter Prospective TrialThis is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid strategy (LR alone)…NCT04356859·Phoenix, Arizona and 25 others

Active not recruitingAttachment Inhibitor Comparison in Heavily Treatment Experienced PatientsThe purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1 patients with…NCT02362503·Los Angeles, California and 138 others

TerminatedVL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in AdultsThe purpose of the trial is to evaluate the safety and efficacy of a new antifungal with a novel mechanism of action in immunocompromised adults with invasive aspergillosis.NCT03327727·Birmingham, Alabama and 27 others

CompletedEvaluate the Efficacy and Safety of M518101 in Subjects With Plaque PsoriasisThis study is to evaluate the efficacy and safety of M518101 in subjects with plaque psoriasisNCT01878461·Mesa, Arizona and 33 others

CompletedTaxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast CancerThe two drugs used to treat metastatic breast cancer in this study may perform better when used together than when used separately.NCT00194740·Seattle, Washington

Enrolling by invitationA Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)This is a multi-national trial. The trial aims to study the long-term safety of LUM-201 in subjects with Idiopathic Pediatric Growth Hormone Deficiency (iPGHD).NCT05796440·Iowa City, Iowa and 6 others

RecruitingDALY II USA/ MB-CART2019.1 for DLBCLDALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with…NCT04792489·Birmingham, Alabama and 31 others

CompletedSafety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's SubjectsLong term safety and efficacy (12 months) of levodopa-carbidopa intestinal gel.NCT00360568·Birmingham, Alabama and 21 others

CompletedLinaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)The objective of LIN-MD-64 is to evaluate the safety and efficacy of 12 weeks of linaclotide therapy (72 μg daily) in comparison with placebo in pediatric participants, 6 to 17…NCT04026113·Birmingham, Alabama and 114 others

CompletedComparison of Two Psycho-educational Family Group Interventions for Persons With SCI and Their CaregiversEach year over 12,000 spinal cord injuries (SCI) occur in the United States.NCT02161913·Spokane, Washington

PreviousPage 212 of 1295Next

Diabetes

in Washington

Heart Diseasein Washington